Influence of H2-receptor- and proton pump inhibitors on some functions of the oxydative and conjugative drug metabolism

Pharmazie

Volumn 51, Issue 7, 1996, Pages 493-497

  Scheuch, E ^a   Walter, R ^a   Hadasova E ^b   Amon, I ^c   Siegmund, W ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b MASARYK UNIVERSITY   (Czech Republic)

^c Asche AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; CYTOCHROME P450; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; NIZATIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; ARYLAMINE ACETYLTRANSFERASE; DRUG; PROTON PUMP;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; LIVER METABOLISM; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; ACETYLATION; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; LIVER MICROSOME; METABOLISM; OXIDATION REDUCTION REACTION; WISTAR RAT;

ACETYLATION; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CYTOCHROME P-450 ENZYME SYSTEM; HISTAMINE H2 ANTAGONISTS; MALE; MICROSOMES, LIVER; OXIDATION-REDUCTION; PHARMACEUTICAL PREPARATIONS; PROTON PUMPS; RATS; RATS, WISTAR;

EID: 0029665201     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Simon, B.; Porro, G. B.; Damman, H. G. (Eds.): Famotidin - Ein Forlschritt in der Therapie säurebedingter Erkrankungen. Thieme-Verlag, Stuttgart/New York 1986
2. Knadler, M.; Bergstrom, R.; Callaghan, C.; Rubin, A.: Drug Metab. Disp. 14, 175 (1986)
3. Nebert, D. W.; Nelson, D. R.; Coon, M. J.; Estabrook, R. W.; Feyereisen, R.; Fujii-Kuriyama, Y.; Gonzalez, F. J.; Guengerich, F. P.; Gunsalus, I. C.; Johnson, E. F.; Loper, J. C.; Sato, R.; Waterman, M. R.; Waxmann, D. J.: DNA 10, 1 (1991)
4. Andersson, T.; Lagerstrom, P. O.; Unge, P.: Ther. Drug Monit. 12, 329 (1990)
5. Pichard, L.; Curi-Pedrosa, R.; Bonfils, C.; Jacqz-Algrain, E.; Domergue, J.; Joyeux, H.; Cosme, J.; Guengerich, F. P.; Maurel, P.: Molec. Pharmac. 47, 410 (1995)
6. Meyer, U. A.: 4. European congress for gastroenterology, Berlin 1995
7. Reimann, I. W.; Klotz, U.; in: Simon, B.; Porro, G. B.; Damman, H. G. (Eds.): Famotidin - Ein Fortschritt in der Therapie säurebedingter Erkrankungen, p. 22, Thieme Verlag Stuttgart/New York 1986
8. Chang, T.; Levine, M.; Bandiera, S. M.; Bellward, G. D.: J. Pharmacol. Exp. Ther. 260, 1441 (1992)
9. Gugler, R.; Jensen, C. J.: Gastroenterology 89, 1235 (1985)
10. Gugler, R.; Jensen, C. J.: Pharmacol. Ther. 33, 133 (1987)
11. Prichard, P. J.; Walt, R. P.; Kitchingman, G. K.: Br. J. Clin. Pharmacol. 24, 543 (1987)
12. Oosterhuis, B.; Jonkmann, J. H. G.; Anderson, T.; Zuiderwijk, P. B. M.: J. Clin. Pharmacol. 32, 470 (1992)
13. Tucker, G. T.: Aliment. Pharmacol. Ther. 8, 33 (1994)
14. Middle, M. V.; Müller, F. O.; Schall, R.; Groenewoud, G.; Hundt, H. K. L.; Huber, R.; Bliesath, H.; Steinijans, V. W.: Pharmacol. Ther. 33, 304 (1995)
15. Svensson, C. K.; Tomilo, M.: Drug Metab. Dispos. 20, 74 (1992)
16. Franke, G.; Hadašová, E.; Kalandrová, V.; Scheuch, E.; Siegmund, W.: Naunyn-Schmiedebergs Arch. Pharmacol. 349, R4 (1994)
17. Gachályi, B.; Vas, A.; Csillag, K.; Nagy, B.; Kocsis, F.; Káldor, A.: Eur. J. Clin. Pharmacol. 31, 613 (1987)
18. Larousse, C.; LeNormand, Y.; Kergueris, M. F.; Veyrac, M. J.; Chaileux, E.; Ordronnean, J.; Moigretean, C.: Int. J. Clin. Pharmacol. Ther. Toxicol. 18, 163 (1980)
19. Siegmund, W.; Franke, G.; Wulkow, R.; Hanke, W.; Thonack, R.: Int. J. Clin. Pharmacol. Ther. Toxicol. 29, 469 (1991)
20. El-Yazigi, A.; Raines, D. A.; Wahab, F. A.; Sieck, J. O.; Ernst, P.; Hatim, A.; Dossing, M.: J. Clin. Pharmacol. 35, 615 (1995)
21. Zidek, Z.; Friebova, M.; Janku, I.; Elis, J.: Biochem. Pharmacol. 26, 69 (1977)
22. Zidek, Z.; Janku, I.: Eur. J. Drug Metab. Pharmacokinet. 6, 255 (1981)
23. Notter, D.; Roland, E.: C. R. Soc. Biol. 172, 531 (1978)
24. Svensson, C. K.; Knowlton, P. W.: Pharm. Res. 6, 477 (1989)
25. Siegmund, W.; Hadašová, E.; Franke, G.; Bleyer, H.; Hübner, G.: Pharmazie 96, 676 (1991)
26. Hadašová, E.; Siegmund, W.; Franke, G.; Schneider, T.; Beyrich, A.; Bleyer, H.; Hübner, G.: Biochem. Pharmacol. 42, 702 (1991)
27. Hadašová, E.; Siegmund, W.; Walter, R.; Scheuch, E.; Franke, G.: Immunopharmacol. Immunotoxicol. 17, 283 (1995)
28. Serlin, M. J.; Challiner, M.; Park, B. M.; Turcan, P. A.; Breckenridge, A. M.: Biochem. Pharmacol. 29, 1971 (1980)
29. Somogyi, A.; Muirhead, M.: Clin. Pharmacokin. 12, 321 (1987)
30. Smith, R.; Kendall, M. J.: Clin. Pharmacokin. 15, 44 (1988)
31. 2-Rezeptor-Antagonisten, Springer Verlag, Berlin/Heidelberg 1989
32. Wright, A. W. E.; Winzor, D. J.; Rally, P. E. B.: Xenobiotica 21, 193 (1991)
33. Bachmann, K. A.; Sullivan, T. J.; Jauregui, L.; Reese, J. H.; Miller; K., Levine, L.: Br. J. Clin. Pharmacol. 36, 380 (1993)
34. Andersson, T.; Miners, J. O.; Veronese, M. E.; Tassaneeyakul, W.; Tassaneeyakul, M.; Meyer, U. A.; Birkett, D. J.: Br. J. Clin. Pharmacol. 37, 597 (1994)
35. Wright, J. T.; Goodman, R. P.; Bethel, A. M. M.; Lambert, C. M.: Clin. Pharmacol. Ther. 35, 285 (1984)
36. Christian, C. D.; Meredith, C. G.; Speeg, K. V.: Clin. Pharmacol. Ther. 36, 221 (1984)
37. Somogyi, A.; McLean, A.; Heinzow, B.: Eur. J. Clin. Pharmacol. 25, 339 (1983)
38. Somogyi, A.; Bochner, F.: Br. J. Clin. Pharmacol. 18, 175 (1985)
39. Higbee, M. D.; Woods, J. S.; Mead, M. R. A.: J. Amer. Geriat. Soc. 32, 162 (1984)
40. Weber, W. W.: The acetylator genes and drug response, Oxford University Press, London 1987
41. Evans, D. A. P.: Pharmacol. Ther. 42, 157 (1989)
42. Deguchi, T.: Biomed. Res. 13, 231 (1992)
43. Thorn, S.; Farrow, P. R.; Santoso, B.; Alberti, K. G. M. M.; Rawlins, M. D.: Br. J. Clin. Pharmacol. 11, 423 (1981)
44. Lindsay, R. M.; Bary, J. D.: Biochem. Pharmacol. 39, 1193 (1990)
45. Olson, H.: Acta Pharmacol. Toxicol. 50, 67 (1982)
46. Olsen, H.; Morland, J.: Br. Med. J. 2, 1260 (1978)
47. Olson, H.; Morland, J.: Br. J. Clin. Pharmacol. 13, 203 (1982)
48. DuSouich, P.; Courteau, H.: Drug Metab. Disp. 9, 279 (1981)
49. Reeves, P. T.; Minchin, R. F.; Ilett, K. F.: Drud Metab. Dispos. 16, 110 (1988)
50. Reeves, P. T.; Minchin, R. F.; Ilett, K. F.: J. Pharmacol. Exp. Ther. 248, 348 (1989)
51. Drobitch, R. K.; Tomilo, M.; Svensson, C. K.: Biochem. Pharmacol. 43, 1643 (1992)
52. Rogerson, T. D.; Wilkinson, C. F.; Hetarski, K.: Biochem. Pharmacol. 26, 1039 (1977)
53. Morris, C. Q.; Tucker, G. T.; Crewe, H. K.; Harlow, J. R.; Woods, H. F.; Lennard, M. S.: Biochem. Pharmacol. 38, 2639 (1989)
54. Gornall, A. G.; Bardawill, C. J.; David, M. M.: J. Biol. Chem. 177, 751 (1949)
55. Greim, H.: Naunyn-Schmiedebergs Arch. Pharmacol. 266, 2370 (1970)
56. Burke, M. D.; Prough, R. A.; Mayer, R. T.: Drug Metab. Dispos. 5, 1 (1977)
57. Greenlee, W. F.; Poland, A.: J. Pharmacol. Exp. Ther. 205, 596 (1978)
58. Nash, T.: Biochem. J. 55, 416 (1953)
59. Reinke, L. A.; Moyer, M. J.: Drug Metab. Dispos. 13, 548 (1985)
60. Schenkmann, J. B.; Remmer, H.: Estabrook, R. W.: Mol. Pharmacol. 3, 113 (1967)